Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-10T14:59:18.839Z Has data issue: false hasContentIssue false
  • English
  • Français

EARLY AWARENESS AND ALERT ACTIVITIES IN LATIN AMERICA: CURRENT SITUATION IN FOUR COUNTRIES

Published online by Cambridge University Press:  14 September 2012

Andres Pichon-Riviere ,
Flávia Tavares Silva Elias ,
Verónica Gallegos Rivero  and
Claudia P. Vaca
Andres Pichon-Riviere
Affiliation:
Institute for Clinical Effectiveness and Health Policy; University of Buenos Aires email: apichon@iecs.org.ar
Flávia Tavares Silva Elias
Affiliation:
Ministry of Health
Verónica Gallegos Rivero
Affiliation:
Ministry of Health
Claudia P. Vaca
Affiliation:
Universidad Nacional de Colombia
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: The aim of this study was to briefly describe the current state of early awareness and alert (EAA) activities and systems in four Latin-American countries (Argentina, Brazil, Colombia, and Mexico).

Methods: Key informants were selected and completed an open questionnaire that included the following domains: current state of EAA activities and systems in each country, potential role for EAA systems in the health system, and future EAA projects that are currently being considered.

Results: In all four countries, health technology assessment (HTA) processes are used to prioritize the use of health resources, albeit at varying degrees and with different mechanisms and methodologies. EAA activities are still limited and there are virtually no institutions or units with specific functions explicitly devoted to EAA activity. However, most countries have developed some initial forms of EAA systems. Being in its initial stages there is no clear differentiation between these early awareness activities and other HTA functions, and no specific methodologies or processes are used to anticipate the emergence of new technologies. Consequently, early evaluation of technologies generally occurs in a reactive manner, after they have been introduced in the market and under the pressure of different stakeholders.

Conclusions: There is growing awareness that the early identification and assessment of emerging technologies should be an integral part of HTA and the decision-making process. Many initiatives are currently focusing on building partnerships between the various regulatory bodies involved in the incorporation of technologies at national levels. It is reasonable to foresee that EAA activities will continue to develop and expand in the region.

Keywords

Horizon ScanningLatin AmericaHealth Technology AssessmentHealth Economic EvaluationsDeveloping Countries
Type
THEME: EARLY AWARENESS AND ALERT (EAA) METHODS AND SYSTEMS
Information
International Journal of Technology Assessment in Health Care , Volume 28 , Issue 3 , July 2012 , pp. 315 - 320
Copyright
Copyright © Cambridge University Press 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Augustovski, F, Bastardo, Y, Caso, A, et al. Pharmacoeconomics and outcomes research in Latin America: Argentina, Brazil, Chile, Colombia, and Mexico. ISPOR Connections. 2008.Google Scholar
2.Banta, D, Almeida, RT. The development of health technology assessment in Brazil. Int J Technol Assess Health Care. 2009;25 (Suppl 1):255–259.CrossRefGoogle ScholarPubMed
3.Banta, D. Health technology assessment in Latin America and the Caribbean. Int J Technol Assess Health Care. 2009;25 (Suppl 1):253–254.CrossRefGoogle ScholarPubMed
4.Brasil, . Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Departamento de Ciência e Tecnologia. Monitoramento do horizonte tecnológico em saúde no âmbito da Rebrats: Proposta preliminar. Brasília: Ministério da Saúde, 2011 52 p. Série B. Textos básicos em saúde. (ISBN: 978-85-334-1807-3).Google Scholar
5.Colombia, . Ministerio de Protección Social. Ley 1438. Por medio de la cual se reforma el Sistema General de Seguridad Social en Salud y se dictan otras disposiciones.,” in MPS, ed., Cap. 5 Art. 92, ley 1438. Ministerio de Protección Social 2011. http://www.minproteccionsocial.gov.co/Normatividad/Forms/AllItems.aspx (accessed July 1, 2011).Google Scholar
6.Colombia, . Ministerio de Protección Social. Ley 1122. Por la cual se hacen algunas modificaciones en el Sistema General de Seguridad Social en Salud y se dictan otras disposiciones. Ministerio de Protección Social 2007, B., ed., Art. 3 -Art. 7, ley 1122. http://www.minproteccionsocial.gov.co/Normatividad/Forms/AllItems.aspx (accessed July 1, 2011).Google Scholar
7.Comisión Técnica Subregional de Evaluación de Tecnologías Sanitarias. Situación de la Evaluación de Tecnologías Sanitarias 2010. [Subregional Technical Committee for Health Technology Assessment. Current status of HTA in the region]. Organismo Andino dde Salud, Convenio Hipólito Unaue, 2010. http://www.orasconhu.org/sites/default/files/Situacion%20ETS%2020%2007%2010_1.pdf (accessed August 1, 2011).Google Scholar
8.Douw, K, Vondeling, H. Selection of new health technologies for assessment aimed at informing decision making: A survey among horizon scanning systems. Int J Technol Assess Health Care. 2006;22:177–183.CrossRefGoogle ScholarPubMed
9.Gomez-Dantes, O, Frenk, J. Health technology assessment in Mexico. Int J Technol Assess Health Care. 2009;25 (Suppl 1):270–275.CrossRefGoogle ScholarPubMed
10.González-Pier, E, Gutiérrez-Delgado, C, Stevens, G, et al.Definición de prioridades para las intervenciones de salud en el Sistema de Protección Social en Salud de México. Salud Publica Mex. 2007;49 (Suppl I):S37–S52.CrossRefGoogle Scholar
11.Guía Para la Elaboración de Informes de Evaluación de Tecnologías Sanitarias. Mercosur (2008) www.saludinvestiga.org.ar/pdf/resoluciones/Res-52-08_ES_GuiaElaboInfTecnoSanit.pdf (accessed July 1, 2011).Google Scholar
12.Iglesias, CP, Drummond, MF, Rovira, J. Health-care decision-making processes in Latin America: Problems and prospects for the use of economic evaluation. Int J Technol Assess Health Care. 2005;21:1–14.CrossRefGoogle ScholarPubMed
13.Lanzamiento de Red de Evaluación de Tecnologías Sanitarias (REDETSA). Pan American Health Organization, 2011. http://new.paho.org/col/index.php?option=com_content&task=view&id=1180&Itemid=259.Google Scholar
14.Mexico, . Secretaría de Salud. Programa de Acción Específico, Evaluación de Tecnologías para la Salud. México, 2008. www.cenetec.salud.gob.mx/descargas/PAES/ETES.pdf (accessed July 1, 2011).Google Scholar
15.O'Malley, S, Jordan, E. Horizon scanning of new and emerging medical technology in Australia: Its relevance to Medical Services Advisory Committee health technology assessments and public funding. Int J Technol Assess Health Care. 2009;25:374–382.CrossRefGoogle ScholarPubMed
16.Pan American Health Organization. Health in the Americas 2007. Volume II: Countries. Scientific and Technical Publication No. 622. Washington, Pan American Health Organization, 2007.Google Scholar
17.Pichon-Riviere, A, Augustovski, F, Rubinstein, A, Garcia-Marti, S, Sullivan, S, Drummond, M. Health technology assessment for resource allocation decisions: Are key principles relevant for Latin America? Int J Technol Assess Health Care. 2010;26:421–427.CrossRefGoogle ScholarPubMed
18.Rubinstein, A, Pichon-Riviere, A, Augustovski, F. Development and implementation of health technology assessment in Argentina: Two steps forward and one step back. Int J Technol Assess Health Care. 2009;25 (Suppl 1):260–269.CrossRefGoogle ScholarPubMed
19.Simpson, S, Packer, C, Carlsson, P, et al.Early identification and assessment of new and emerging health technologies: Actions, progress, and the future direction of an international collaboration—EuroScan. Int J Technol Assess Health Care. 2008;24:518–525.CrossRefGoogle ScholarPubMed
20.Singer, ME. Cost-effectiveness analysis: Developing nations left behind. Pharmacoeconomics. 2008;26:359–361.CrossRefGoogle ScholarPubMed
21.Stevens, A, Packer, C, Robert, G. Early warning of new health care technologies in the United Kingdom. Int J Technol Assess Health Care. 1998;14:680–686.CrossRefGoogle ScholarPubMed
22.Tobar, F. Economía de los medicamentos genéricos en América Latina. Rev Panam Salud Publica. 2008:59–67.CrossRefGoogle Scholar